Pfizer Inc. et al v. MSN Pharmaceuticals Inc. et al
| Pfizer Inc, Pfizer Inc., Warner-Lambert Company LLC and PF Prism IMB B.V. |
| MSN Pharmaceuticals Inc, MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited |
| DE/1:21-CV-00139 |
| February 3, 2021 |
| Judicial Panel on Multidistrict Litigation |
| Colm F Connolly |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 23, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 MINUTE ORDER CLOSING BRIEFING re: pldg. ( #1 in MDL No. 2990), ( #2 in MDL No. 2990) Briefing in this matter is now closed. The parties to actions on the motion(s) remain under a duty, pursuant to Panel Rules 6.1(f) and 6.2(d), to notify the Clerk of the Panel promptly of potential tag-along actions, as well as any development that moots the motion or fully disposes of any action on the motion. Parties in any potential tag-along action may file an Interested Party response, but must do so promptly, and in any event, no later than the Thursday prior to the hearing session at which the motion for transfer is to be heard by the Panel.Signed by Clerk of the Panel John W. Nichols on 3/23/2021. Associated Cases: MDL No. 2990, DE/1:20-cv-01392, DE/1:20-cv-01393, DE/1:20-cv-01396, DE/1:20-cv-01407, DE/1:20-cv-01528, DE/1:20-cv-01530, DE/1:21-cv-00034, DE/1:21-cv-00078, DE/1:21-cv-00139, WVN/1:20-cv-00244 (JC) |
| Filing 11 RESPONSE -- (re: pldg. ( 1 in MDL No. 2990) ) Filed by Defendant Mylan Pharmaceuticals Inc. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2990, DE/1:20-cv-01392, DE/1:20-cv-01393, DE/1:20-cv-01396, DE/1:20-cv-01407, DE/1:20-cv-01528, DE/1:20-cv-01530, DE/1:21-cv-00034, DE/1:21-cv-00078, DE/1:21-cv-00139, WVN/1:20-cv-00244 (Copland, Gordon) Modified on 3/16/2021 (DP)(EDITED PARTY TYPE). |
| Filing 10 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #2 in MDL No. 2990) -- Identifying Corporate Parent Aurobindo Pharma Limited for Eugia Pharma Specialties Ltd.. (Attachments: #1 Exhibit A, #2 Proof of Service) Associated Cases: MDL No. 2990, DE/1:20-cv-01392, DE/1:20-cv-01393, DE/1:20-cv-01396, DE/1:20-cv-0140 7, DE/1:20-cv-01528, DE/1:20-cv-01530, DE/1:21-cv-00034, DE/1:21-cv-00078, DE/1:21-cv-00139, WVN/1:20-cv-00244 (Dorsney, Kenneth) |
| Filing 9 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #2 in MDL No. 2990) -- Identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc.. (Attachments: #1 Exhibit A, #2 Proof of Service) Associated Cases: MDL No. 2990, DE/1:20-cv-01392, DE/1:20-cv-01393, DE/1:20-cv-01396, DE/1:20-cv-01407, DE/1:20-cv-01528, DE/1:20-cv-01530, DE/1:21-cv-00034, DE/1:21-cv-00078, DE/1:21-cv-00139, WVN/1:20-cv-00244 (Dorsney, Kenneth) |
| Filing 8 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #2 in MDL No. 2990) -- Identifying Corporate Parent No Parent Corp. for Aurobindo Pharma, Ltd.. (Attachments: #1 Exhibit A, #2 Proof of Service) Associated Cases: MDL No. 2990, DE/1:20-cv-01392, DE/1:20-cv-01393, DE/1:20-cv-01396, DE/1:20-cv-01407, DE/1:20-cv-01 528, DE/1:20-cv-01530, DE/1:21-cv-00034, DE/1:21-cv-00078, DE/1:21-cv-00139, WVN/1:20-cv-00244 (Dorsney, Kenneth) |
| Filing 7 NOTICE OF APPEARANCE re: pldg.( #2 in MDL No. 2990) Filed by Kenneth Laurence Dorsney on behalf of Defendants Aurobindo Pharma USA, Inc., #et al.Aurobindo Pharma, Ltd., Eugia Pharma Spe cialties Ltd. #[Suppress List] (Attachments: #1 Exhibit A, #2 Proof of Service) Associated Cases: MDL No. 2990, DE/1:20-cv-01392, DE/1:2 0-cv-01393, DE/1:20-cv-01396, DE/1:20-cv-01407, DE/1:20-cv-01528, DE/1:20-cv-01530, DE/1:21-cv-00034, DE/1:21-cv-00078, DE/1:21-cv-00139, WVN/1:20-cv-00244 (Dorsney, Kenneth) |
| Filing 6 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2990) -- Identifying Corporate Parent Pfizer Inc. for PF PRISM IMB B.V. (Attachments: #1 Exhibit A, #2 Proof of Service) Associated Cases: MDL No. 2990, DE/1:20-cv-01392, DE/1:20-cv-01393, DE/1:20-cv-01396, DE/1:20-cv-01407, DE/1:20-cv-01528, DE/1:20-cv-01530, DE/1:21-cv-00034, DE/1:21-cv-00078, DE/1:21-cv-00139, WVN/1:20-cv-00244 (Mandernach, Christopher) Modified on 3/9/2021 (DP)(REMOVED DUPLICATE PARTY NAMES). |
| Filing 5 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2990) -- Identifying Corporate Parent Pfizer Inc. for Warner-Lambert Company LLC. (Attachments: #1 Exhibit A, #2 Proof of Service) Associated Cases: MDL No. 2990, DE/1:20-cv-01392, DE/1:20-cv-01393, DE/1:20-cv-01396, DE/1:20-cv-01407, DE/1:20-cv-01528, DE/1:20-cv-01530, DE/1:21-cv-00034, DE/1:21-cv-00078, DE/1:21-cv-00139, WVN/1:20-cv-00244 (Mandernach, Christopher) Modified on 3/9/2021 (DP)(REMOVED DUPLICATE PARTY NAMES). |
| Filing 4 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2990) -- Identifying Corporate Parent No Parent Corp. for Pfizer Inc.(Attachments: #1 Exhibit A, #2 Proof of Service) Associated Cases: MDL No. 2990, DE/1:20-cv-01392, DE/1:20-cv-01393, DE/1:20-cv-01396, DE/1:20-cv-01407, DE/1:20-cv-01528, DE/1:20-cv-01530, DE/1:21-cv-00034, DE/1:21-cv-00078, DE/1:21-cv-00139, WVN/1:20-cv-00244 (Mandernach, Christopher) Modified on 3/9/2021 (DP)(REMOVED PARTY NAME). |
| Filing 3 NOTICE OF APPEARANCE re: pldg.( 1 in MDL No. 2990) Filed by Christopher J Mandernach on behalf of Plaintiffs PF Prism IMB B.V., #et al.Pfizer Inc., Warner-Lambert Company LLC #[Suppress List] (Attachments: #1 Exhibit A, #2 Proof of Service) Associated Cases: MDL No. 2990, DE/1:20-cv-01392, DE/1:20-cv-01393, DE/1:20-cv-01396, DE/1:20-cv-01407, DE/1:20-cv-01528, DE/1:20-cv-01530, DE/1:21-cv-00034, DE/1:21-cv-00078, DE/1:21-cv-00139, WVN/1:20-cv-00244 (Mandernach, Christopher) Modified on 3/9/2021 (DP)(REMOVED DUPLICATE PARTY NAMES). |
| Filing 2 ***TEXT ONLY NOTICE***NOTICE OF FILING AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #1 in MDL No. 2990) BRIEFING SCHEDULE IS SET AS FOLLOWS:< br< Notices of Appearance due on or before 3/8/2021. Corporate Disclosure Statements due on or before 3/8/2021. Responses due on or before 3/15/2021. Reply, if any, due on or before 3/22/2021. In their briefs, the parties should address what steps they have taken to pursue alternatives to centralization (including, but not limited to, engaging in informal coordination of discovery and scheduling, and seeking Section 1404 transfer of one or more of the subject cases). #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines < Forms page of our website for additional information.Signed by Clerk of the Panel John W. Nichols on 2/22/2021. Associated Cases: MDL No. 2990, DE/1:20-cv-01392, DE/1:20-cv-01393, DE/1:20-cv-01396, DE/1:20-cv-01407, DE/1:20-cv-01528, DE/1:20-cv-01530, DE/1:21-cv-00034, DE/1:21-cv-00078, DE/1:21-cv-00139, WVN/1:20-cv-00244 (CMD) |
| Filing 1 MDL Number 2990 Assigned -- MOTION FOR TRANSFER ACCEPTED FOR FILING re: pldg. ( #1 in Pending No. 7) Associated Cases: Pending No. 7, DE/1:20-cv-01392, DE/1:20-cv-01393, DE/1:20-cv-01 396, DE/1:20-cv-01407, DE/1:20-cv-01528, DE/1:20-cv-01530, DE/1:21-cv-00034, DE/1:21-cv-00078, DE/1:21-cv-00139, WVN/1:20-cv-00244 (CMD) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
